About FDA


FY 2009 MDUFA Performance Report Table of Contents

FDA continues to encourage meetings with regulated industry as an effective way to ensure that both FDA and applicants understand the clinical, scientific, and regulatory issues associated with new technologies. Pre-IDE, pre-PMA, device pre-IND, and device pre-BLA meetings have shown to be beneficial and are used routinely by industry. More formal types of meetings (agreement, determination, and 100-day meetings) are also available, but are not used as frequently by premarket applicants.

Next page: Quarterly Performance Reports

Page Last Updated: 09/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English